RxDoctor Payments Data

Patrick Canan, DO

Family Medicine · Annapolis, MDNPI 1306845375

Payments from drug & device makers

$1,747in general payments, 2019–2025

Across 94 payments — averaging $18.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$301
  • Exact Sciences$237
  • Amgen$180
  • Pfizer$177
  • AbbVie$113
  • Novartis$113
  • plus $626 from 15 others

What the payments were for

  • Food & beverage$1,66795%
  • Education$805%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,747 in reported general payments places this provider in the 75th percentile of 1,193 family medicine providers in Maryland.

See all family medicine providers in Maryland

Medicare billing

Part B allowed, 2024
$121,549
Medicare patients
353
Services billed
1,481

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide31$41,314
EliquisApixaban25$31,904
JanuviaSitagliptin Phosphate12$19,438
JanumetSitagliptin Phos/Metformin Hcl15$12,757
Rosuvastatin Calcium134$4,934
Atorvastatin Calcium150$2,322
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog11$2,167
Amlodipine Besylate236$2,049
Ezetimibe34$1,733
Pantoprazole Sodium79$1,218
Escitalopram Oxalate57$1,135
Celecoxib20$1,100
Lisinopril92$1,046
Losartan Potassium67$871
Albuterol Sulfate HfaAlbuterol Sulfate35$793

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$301$41,31431 claims
MerckJanuvia, Janumet$32$32,19527 claims
PfizerEliquis$177$31,90425 claims
AbbVieSynthroid$113$28113 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 1,193 family medicine providers in Maryland.

Other family medicine in Annapolis

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →